3Y Annualised Return
▲65.36%
5Y Annualised Return
▲44.27%
10Y Annualised Return
▲3.40%
Kabra Drugs Stock Performance
|
|
|
Kabra Drugs Company background
Founded in: 1989
Managing director: N Aravind
Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence.With manufacturing and regular supply in the domestic market for injectables, soft gelatin capsules and liquids (oral and external especially alcohol products) the company now looks at the global market. A number of new products have been developed for the same.Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. These are WHOGMP, cGMP Schedule M approved facilities which also helps to get business approvals for Government, Semi Government under takings , big institutions and other N.G.Os. Besides, they are also actively involved in trading and marketing of biological APIs and Biochemicals.Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have already been undertaken by the Company.
As of 14 Aug, 2025, Kabra Drugs share price is ₹20.3. The stock opened at ₹19.5 and had closed at ₹20.2 the previous day. During today’s trading session, Kabra Drugs share price moved between ₹19.52 and ₹21.09, with an average price for the day of ₹20.30. Over the last 52 weeks, the stock has recorded a low of ₹8.71 and a high of ₹22.77. In terms of performance, Kabra Drugs share price has increased by 92.4% over the past six months and has increased by 131.80% over the last year.
Kabra Drugs SIP Return Calculator
Over the past
3 years
5 years
Total Investment of ₹1,95,00,000
Would have become ₹6,06,92,376 (+211.24%)
Daily SIP of ₹25,000 would have become ₹6,06,92,376 in 3 years with a gain of ₹4,11,92,376 (+211.24%)
Kabra Drugs Fundamental
Market Cap (in crs)
48.17
Face Value
10
Turnover (in lacs)
9.23
Key Metrics
Qtr Change %
133.30% Gain from 52W Low
74.7
Dividend yield 1yr %
0
Kabra Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
0.00
Current Price
5Day EMA
20.40
10Day EMA
20.30
12Day EMA
20.20
20Day EMA
19.90
26Day EMA
19.50
50Day EMA
17.50
100Day EMA
14.30
200Day EMA
10.80
5Day SMA
20.60
10Day SMA
20.30
20Day SMA
20.00
30Day SMA
20.10
50Day SMA
17.30
100Day SMA
13.10
150Day SMA
10.30
200Day SMA
9.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 45428 Rs | 45428 Rs |
Week Rs | 45789 Rs | 45789 Rs |
Month Rs | 77247 Rs | 77247 Rs |
Resistance & Support
20.31
Pivot
Resistance
First Resistance
21.10
Second Resistance
21.88
Third Resistance
22.67
Support
First Support
19.53
Second support
18.74
Third Support
17.96
Relative Strength Index
57.13
Money Flow Index
54.34
MACD
0.77
MACD Signal
0.95
Average True Range
1.39
Average Directional Index
38.61
Rate of Change (21)
0.00
Rate of Change (125)
377
Kabra Drugs Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 50.05 | 37.23 | 61 | 39.88 | -2.38% | -8.83% | -10.42% | -16.24% | -10.00% | 0.00% | 102.92 | 101.18 | 0.74 | |
- | 46.73 | 43.75 | 69.5 | 47.75 | 1.15% | -2.58% | -9.30% | -15.91% | -27.26% | 0.00% | 30.23 | 40.57 | 1.11 | |
- | 48.85 | 8.42 | 33.49 | 10.04 | -5.34% | -21.37% | -58.83% | -60.78% | -70.18% | 0.00% | 54.33 | 40.57 | 0.59 | |
JFL Life Sciences Ltd. | 13.55 | 13.55 | - | - | - | - | - | - | - | - | - | - | - | - |
- | 46.00 | 6.4 | 26.31 | 20.02 | -8.16% | -24.98% | 43.19% | 169.82% | 0.00% | 0.00% | 46.66 | 40.57 | 1.19 | |
- | 50.86 | 35.7 | 69.7 | 42.50 | 4.71% | 0.00% | -1.79% | -13.74% | 0.00% | 0.00% | 7.03 | 40.57 | 1.22 |
Kabra Drugs Share Price FAQs
How to buy Kabra Drugs shares?
You can easily buy Kabra Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Kabra Drugs ?
The 52-week high and low of Kabra Drugs share price is ₹22.77 and ₹8.71 as of 14/8/2025.
Please be aware that Kabra Drugs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account